Ezaki Glico Co., Ltd. carries a market capitalization of 338.14B, placing it among publicly traded companies globally. Its enterprise value stands at 205.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 338.14B |
| Enterprise Value | 205.19B |
Ezaki Glico Co., Ltd. currently has 63.60M shares outstanding.
| Shares Outstanding | 63.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Ezaki Glico Co., Ltd. trades at a trailing price-to-earnings ratio of 26.63. The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 1.13.
| PE Ratio | 26.63 |
| PS Ratio | 0.80 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Ezaki Glico Co., Ltd. trades at an EV/EBITDA multiple of 10.57 and an EV/FCF ratio of 3,444.59. The EV/Sales ratio of 0.62 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.57 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.62 |
| EV / EBITDA | 10.57 |
| EV / EBIT | 10.57 |
| EV / FCF | 3,444.59 |
Ezaki Glico Co., Ltd. maintains a current ratio of 1.97, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.07, indicating conservative leverage, while an interest coverage ratio of 208.72 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.97 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.01 |
| Interest Coverage | 208.72 |
Ezaki Glico Co., Ltd. posts a return on equity of 4.29 and a return on invested capital of 4.37.
| Return on Equity (ROE) | 4.29 |
| Return on Assets (ROA) | 2.66 |
| Return on Invested Capital (ROIC) | 4.37 |
| Return on Capital Employed (ROCE) | 4.01 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.25 |
Over the trailing twelve months, Ezaki Glico Co., Ltd. has paid 5.65B in income taxes, reflecting an effective tax rate of 35.95.
| Income Tax | 5.65B |
| Effective Tax Rate | 35.95 |
Ezaki Glico Co., Ltd.'s stock has gained approximately 16.08498% over the past 52 weeks. The 50-day moving average sits at 5,457.90, while the 200-day moving average is 5,508.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16.08498% |
| 50-Day Moving Average | 5,457.90 |
| 200-Day Moving Average | 5,508.23 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Ezaki Glico Co., Ltd. generated 333.48B in revenue and converted that into 9.98B in net income, yielding earnings per share of 158.19. EBITDA reached 19.41B, while operating income came in at 19.41B.
| Revenue | 333.48B |
| Gross Profit | 128.68B |
| Operating Income | 19.41B |
| Pretax Income | 15.70B |
| Net Income | 9.98B |
| EBITDA | 19.41B |
| EBIT | 19.41B |
| Earnings Per Share (EPS) | 158.19 |
Ezaki Glico Co., Ltd. holds 61.45B in cash and equivalents against 190.00M in total debt, resulting in a net debt position of -61.25B. Total book value stands at 235.13B, with working capital of 76.13B providing operational flexibility.
| Cash & Cash Equivalents | 61.45B |
| Total Debt | 190.00M |
| Net Debt | -61.25B |
| Equity (Book Value) | 235.13B |
| Book Value Per Share | 3,698.00 |
| Working Capital | 76.13B |
Ezaki Glico Co., Ltd. operates with a gross margin of 38.59, reflecting its pricing power and cost economics. The operating margin of 5.82 and net profit margin of 2.99 provide insight into operational efficiency.
| Gross Margin | 38.59 |
| Operating Margin | 5.82 |
| Pretax Margin | 4.71 |
| Profit Margin | 2.99 |
| EBITDA Margin | 5.82 |
Ezaki Glico Co., Ltd.'s most recent stock split took place on September 26, 2014 with a 2:1 split ratio.
| Last Split Date | 9/26/2014 |
| Split Ratio | 2:1 |
Ezaki Glico Co., Ltd. posts an Altman Z-Score of 3.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.99 |